Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
3.715 USD | +0.13% | -3.90% | +21.31% |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
+21.31% | 312M | |
-3.30% | 102B | |
+2.26% | 96.84B | |
-0.44% | 21.48B | |
-18.51% | 20.82B | |
-7.45% | 18.6B | |
-40.31% | 16.81B | |
-26.30% | 13.78B | |
+0.52% | 13.4B | |
+20.85% | 11.06B |
- Stock Market
- Equities
- AVIR Stock
- News Atea Pharmaceuticals, Inc.
- Atea Pharmaceuticals Says It Dosed First Patient in Phase 3 Trial of Bemnifosbuvir to Treat COVID-19